These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31714373)

  • 1. Direct, Absenteeism, and Disability Cost Burden of Obesity Among Privately Insured Employees: A Comparison of Healthcare Industry Versus Other Major Industries in the United States.
    Ramasamy A; Laliberté F; Aktavoukian SA; Lejeune D; DerSarkissian M; Cavanaugh C; Smolarz BG; Ganguly R; Duh MS
    J Occup Environ Med; 2020 Feb; 62(2):98-107. PubMed ID: 31714373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and Indirect Cost of Obesity Among the Privately Insured in the United States: A Focus on the Impact by Type of Industry.
    Ramasamy A; Laliberté F; Aktavoukian SA; Lejeune D; DerSarkissian M; Cavanaugh C; Smolarz BG; Ganguly R; Duh MS
    J Occup Environ Med; 2019 Nov; 61(11):877-886. PubMed ID: 31425324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The direct and indirect costs among U.S. privately insured employees with hypogonadism.
    Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R
    J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.
    Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D
    Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
    Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
    Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of epilepsy among the privately insured in the US.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
    Pharmacoeconomics; 2010; 28(8):675-85. PubMed ID: 20623993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
    Gilligan AM; Foster SA; Sainski-Nguyen A; Sedgley R; Smith D; Morrow P
    J Occup Environ Med; 2018 Dec; 60(12):1120-1127. PubMed ID: 30199470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating quantitative and qualitative approaches to assess wintertime illness-related absenteeism and its direct and indirect costs among the private sector in Ulaanbaatar.
    Ganbat M; Erdenebileg N; Batbold C; Nergui S; Anderson R; Wigfall C; Amarsanaa N; Heikens A; Sarantuya M; Warburton D
    PLoS One; 2022; 17(2):e0263220. PubMed ID: 35113912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of sarcoidosis in a commercially-insured population in the United States.
    Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ
    J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
    Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
    Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic impact of bipolar disorder in an employed population from an employer perspective.
    Gardner HH; Kleinman NL; Brook RA; Rajagopalan K; Brizee TJ; Smeeding JE
    J Clin Psychiatry; 2006 Aug; 67(8):1209-18. PubMed ID: 16965198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
    White LA; Birnbaum HG; Kaltenboeck A; Tang J; Mallett D; Robinson RL
    J Occup Environ Med; 2008 Jan; 50(1):13-24. PubMed ID: 18188077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between employee obesity and employer costs: evidence from a panel of U.S. employers.
    Van Nuys K; Globe D; Ng-Mak D; Cheung H; Sullivan J; Goldman D
    Am J Health Promot; 2014; 28(5):277-85. PubMed ID: 24779722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absenteeism and Employer Costs Associated With Chronic Diseases and Health Risk Factors in the US Workforce.
    Asay GR; Roy K; Lang JE; Payne RL; Howard DH
    Prev Chronic Dis; 2016 Oct; 13():E141. PubMed ID: 27710764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and absence of HCV-infected employees by disease stage.
    Baran RW; Samp JC; Walker DR; Smeeding JE; Young JW; Kleinman NL; Brook RA
    J Med Econ; 2015; 18(9):691-703. PubMed ID: 26047262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional dyspepsia impacts absenteeism and direct and indirect costs.
    Brook RA; Kleinman NL; Choung RS; Melkonian AK; Smeeding JE; Talley NJ
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):498-503. PubMed ID: 20304102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis.
    Kleinman NL; Cifaldi MA; Smeeding JE; Shaw JW; Brook RA
    J Occup Environ Med; 2013 Mar; 55(3):240-4. PubMed ID: 23471034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health and disability costs of depressive illness in a major U.S. corporation.
    Druss BG; Rosenheck RA; Sledge WH
    Am J Psychiatry; 2000 Aug; 157(8):1274-8. PubMed ID: 10910790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.